サインイン 無料でサインアップします。

Intercept Pharmaceuticals Incの債務/株式

Intercept Pharmaceuticals Incの債務/株式は何ですか。

Intercept Pharmaceuticals Incの債務/株式は7.17です。

債務/株式の定義は何ですか。



負債比率は、株主資本と企業資産の融資に使用される負債の相対的割合を示す財務比率です。

The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.

NASDAQのセクタHealth Careにおける債務/株式の企業と比べるIntercept Pharmaceuticals Inc

Intercept Pharmaceuticals Incは何をしますか。

we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.

Intercept Pharmaceuticals Incと類似の債務/株式